EyePoint Inc (STU:PV3B)
€ 3.66 +0.040 (+1.1%) Market Cap: 316.04 Mil Enterprise Value: 177.47 Mil PE Ratio: 0 PB Ratio: 2.18 GF Score: 38/100

EyePoint Inc at Citi Biopharma Back to School Summit Transcript

Sep 9, 2026 / 12:00 PM GMT
Release Date Price: €3.7 (-4.64%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EYPT.OQ - EyePoint Inc
EyePoint Inc at Citi Biopharma Back to School Summit
Sep 09, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
So welcome everyone to day one of Citi's back to school biopharma conference here in New York City. Great to be back in New York. Miguel Nachamovitz, one of the biotech analysts here at Citi. So our first session, it's my great pleasure to welcome the management of iPoint Inc. We have Jay Duker, President and CEO, George Elston. EPP and CFO and Ramiro Ribeiro, the CMO of the company. So welcome all of you.

Thank you very much. Thanks for having us. Of course.

So obviously a lot's happened. You've had some phase three data. You have another important, very important phase three result coming up soon in the fall.

So Jay, maybe just to level set, if you could just introduce the company, introduce the goals
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot